Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $43,052 | 1 | 98.7% |
| Food and Beverage | $494.51 | 6 | 1.1% |
| Education | $89.99 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $43,052 | 1 | $0 (2018) |
| ABBVIE INC. | $120.98 | 1 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $117.68 | 1 | $0 (2017) |
| ABIOMED | $110.33 | 1 | $0 (2024) |
| Covidien LP | $96.72 | 1 | $0 (2017) |
| Janssen Biotech, Inc. | $89.99 | 1 | $0 (2017) |
| Intercept Pharmaceuticals, Inc. | $36.91 | 1 | $0 (2018) |
| Genentech, Inc. | $11.89 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $231.31 | 2 | ABBVIE INC. ($120.98) |
| 2019 | $11.89 | 1 | Genentech, Inc. ($11.89) |
| 2018 | $43,089 | 2 | PFIZER INC. ($43,052) |
| 2017 | $304.39 | 3 | Bayer HealthCare Pharmaceuticals Inc. ($117.68) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $120.98 | General |
| Category: IMMUNOLOGY | ||||||
| 02/27/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $110.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2019 | Genentech, Inc. | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: None | ||||||
| 07/01/2018 | PFIZER INC. | — | Grant | Cash or cash equivalent | $43,052.35 | General |
| 04/13/2018 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $36.91 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
| 08/23/2017 | Janssen Biotech, Inc. | REMICADE (Biological) | Education | In-kind items and services | $89.99 | General |
| Category: Immunology | ||||||
| 08/12/2017 | Covidien LP | PillCam (Device) | Food and Beverage | In-kind items and services | $96.72 | General |
| Category: GIH | ||||||
| 06/21/2017 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $117.68 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 388 | 412 | $235,291 | $24,196 |
| 2022 | 11 | 325 | 353 | $167,589 | $21,454 |
| 2021 | 7 | 201 | 224 | $101,501 | $11,546 |
| 2020 | 4 | 97 | 116 | $24,075 | $6,333 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 25 | 26 | $49,369 | $5,214 | 10.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 54 | 56 | $63,332 | $4,112 | 6.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 39 | 40 | $63,981 | $3,979 | 6.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 22 | $9,878 | $2,899 | 29.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 24 | $7,657 | $2,628 | 34.3% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Facility | 2023 | 23 | 24 | $10,722 | $2,006 | 18.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 16 | $3,742 | $1,490 | 39.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 16 | $3,756 | $989.95 | 26.4% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 2023 | 111 | 114 | $18,183 | $441.43 | 2.4% |
| 91065 | Measurement of hydrogen in breath to test for stomach and bowel symptoms | Office | 2023 | 55 | 56 | $1,799 | $360.96 | 20.1% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 17 | 18 | $2,871 | $75.42 | 2.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 33 | 33 | $13,933 | $5,077 | 36.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 30 | 30 | $46,838 | $2,946 | 6.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 16 | 16 | $29,000 | $2,708 | 9.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 27 | $5,852 | $2,150 | 36.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 21 | $6,384 | $2,082 | 32.6% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Facility | 2022 | 20 | 21 | $9,382 | $1,634 | 17.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 21 | 21 | $23,722 | $1,487 | 6.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 23 | $5,100 | $1,459 | 28.6% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 11 | 12 | $11,637 | $1,095 | 9.4% |
| 91065 | Measurement of hydrogen in breath to test for stomach and bowel symptoms | Office | 2022 | 60 | 63 | $2,024 | $476.22 | 23.5% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 2022 | 48 | 50 | $7,975 | $186.64 | 2.3% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 35 | 36 | $5,742 | $152.93 | 2.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 28 | 47 | $10,199 | $3,548 | 34.8% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Office | 2021 | 23 | 24 | $37,042 | $3,081 | 8.3% |
About Amir Kashani
Amir Kashani is a Gastroenterology healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2008. The National Provider Identifier (NPI) number assigned to this provider is 1316125909.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amir Kashani has received a total of $43,637 in payments from pharmaceutical and medical device companies, with $231.31 received in 2024. These payments were reported across 8 transactions from 8 companies. The most common payment nature is "Grant" ($43,052).
As a Medicare-enrolled provider, Kashani has provided services to 1,011 Medicare beneficiaries, totaling 1,105 services with total Medicare billing of $63,528. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Internal Medicine, Gastroenterology
- Location Salt Lake City, UT
- Active Since 02/06/2008
- Last Updated 10/29/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1316125909
Products in Payments
- SKYRIZI (Biological) $120.98
- Stivarga (Drug) $117.68
- Impella (Device) $110.33
- PillCam (Device) $96.72
- REMICADE (Biological) $89.99
- OCALIVA (Drug) $36.91
- Non-Covered Product (Drug) $11.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Salt Lake City
Richard Gilroy, Md, MD
Gastroenterology — Payments: $252,278
Kathryn Peterson, Md, MD
Gastroenterology — Payments: $94,047
Dr. Peder Pedersen, M.d, M.D
Gastroenterology — Payments: $67,521
Dr. Juan Gallegos-Orozco, M.d, M.D
Gastroenterology — Payments: $30,877
Iqbal Sandhu, Md, MD
Gastroenterology — Payments: $18,270
John Fang, Md, MD
Gastroenterology — Payments: $14,387